GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc., filing under ticker CPSR, represents the SPAC vehicle formerly known as Capstar Special Purpose Acquisition Corp, which completed its initial public offering in 2020 targeting the healthcare and biotech sector. The company filed a Form 10-Q on July 8, 2021, reflecting its financial position during the period following its announced business combination with Gelesis, a biotech firm developing a superabsorbent hydrogel platform for weight management, including its FDA-cleared product Plenity. At the time of the filing the de-SPAC transaction had not yet closed. Investors and analysts seeking full filing history, sponsor details, and deal documentation for CPSR can sign up for complete data access on SpacDesk.